AGP Executive Report
Last update: 2 hours agoHepatitis B Trial Halted: A controversial U.S.-funded study involving newborns in Guinea-Bissau will not proceed, a lead researcher said, after the government withheld approval. The plan would have delayed the birth dose for about 7,000 babies until six weeks of age. Judicial police seized vaccine doses from the Bandim Health Project during an investigation, but said the seizure alone did not indicate any problem with the vaccines’ quality, safety or effectiveness. Health experts have urged faster access to the birth dose, which the country plans to introduce universally in 2028. Polio Prevention: WHO warns that funding shortfalls and gaps in vaccination coverage threaten Africa’s polio-eradication efforts, calling for stronger domestic investment and reliable support for immunisation campaigns.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
